Dongyue Subsidiary Forecasts Fourfold Profit Surge in First Quarter of 2026

Dongyue Group Limited ( (HK:0189) ) just unveiled an update.

Dongyue Group has disclosed that its non-wholly owned subsidiary, Shandong Dongyue Organosilicone Materials, listed on ChiNext in Shenzhen, expects a sharp rebound in profitability for the quarter ended 31 March 2026. The subsidiary estimates net profit attributable to shareholders at RMB183 million to RMB203 million, up about 397% to 451% year on year, with net profit after non-recurring items projected at RMB205 million to RMB225 million, an increase of roughly 424% to 475%.

The company emphasized that these figures are based on internal management records and have not yet been audited or reviewed under Dongyue Group’s accounting standards, and it urged shareholders and potential investors to exercise caution in relying on the preview. The strong preliminary performance at the organosilicone unit signals a significant earnings recovery that could bolster the group’s overall financial results, but the lack of external verification means the extent of the uplift will only be confirmed once formal quarterly accounts are released.

The most recent analyst rating on (HK:0189) stock is a Hold with a HK$13.00 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.

More about Dongyue Group Limited

Dongyue Group Limited is a Cayman Islands–incorporated company listed in Hong Kong, with operations in China’s chemical sector through subsidiaries such as Shandong Dongyue Organosilicone Materials Co., Ltd. The group’s business includes organosilicone materials, and its market focus extends to both domestic and international downstream industrial users of specialty chemical products.

Average Trading Volume: 14,260,730

Technical Sentiment Signal: Buy

Current Market Cap: HK$18.43B

Find detailed analytics on 0189 stock on TipRanks’ Stock Analysis page.